Hemogenyx Pharmaceuticals PLC (HEMO) — Free Cash Flow Generation Index

Latest as of June 2017: 0.53x

Hemogenyx Pharmaceuticals PLC (HEMO) has a Free Cash Flow Generation Index of 0.53x as of June 2017. Free cash flow of GBX12.24 represents 1% of operating cash flow (GBX23.26). See Hemogenyx Pharmaceuticals PLC (HEMO) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

0.53x

Free Cash Flow / Operating CF

Free Cash Flow

GBX12.24

GBX

Operating Cash Flow

GBX23.26

GBX

Capital Expenditures

GBX11.02

GBX

Hemogenyx Pharmaceuticals PLC Free Cash Flow Generation Index (2015–2015)

Historical FCF Generation Index trend for Hemogenyx Pharmaceuticals PLC across 1 annual periods. Explore debt repayment capacity of Hemogenyx Pharmaceuticals PLC to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Hemogenyx Pharmaceuticals PLC (2015–2015)

Year-by-year Free Cash Flow Generation Index for Hemogenyx Pharmaceuticals PLC. For the full company profile including market capitalisation, see market value of Hemogenyx Pharmaceuticals PLC.

Year	FCG Index	Free Cash Flow (GBX)	Operating CF	Capital Expenditures	YoY Change
2015	1.00x	GBX79.71	GBX79.71	GBX0.00	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).